#121 - Azra Raza, M.D.: Why we're losing the war on cancer

Azra Raza is a physician, scientist, author, and outspoken advocate for reconfiguring the current model of research in cancer. In this episode, Azra discusses the content of her book, The First Cell, which takes a critical look at the outdated models being used to study cancer resulting in a lack of progress in survival rates for cancer patients. Azra offers a solution which focuses on early detection and prevention, and she concludes with an optimistic outlook for the future of cancer research. We discuss: • Azra’s upbringing, interest in oncology, and the basis for writing her book [3:30]; • The lack of progress in cancer treatment over the decades [18:45]; • What is holding the oncology field back? [33:15]; • Do the purported advances in oncology reflect the billions of dollars spent on cancer research? [40:00]; • Economics of new cancer drugs—how small increases in survival come with staggering financial burdens [47:00]; • How good intentions can still lead to misaligned incentives and a broken system [1:03:00]; • Why 95% of new cancer drugs fail—a critical review of the cancer research model [1:11:15]; • Early detection and prevention—a potential solution to the cancer problem [1:22:30]; • Coping with the loss of her husband to cancer [1:46:00]; • Azra’s optimistic view of the future [1:49:30]; and • More. Learn more: https://peterattiamd.com/ Show notes page for this episode: https://peterattiamd.com/azraraza Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Connect with Peter on Facebook | Twitter | Instagram.

Release date

Lydbog: 27. juli 2020